Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Ness, Gregory M DDS

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Correction of Farsightedness in Children Study

Not Applicable

Completed

Conditions: Farsightedness
Hyperopia

Interventions: Device: Control
Device: Spectacles

First Posted Date: 2007-05-11

Last Posted Date: 2023-04-18

Lead Sponsor: Ohio State University

Target Recruit Count: 58

Registration Number: NCT00472212

Locations: 🇺🇸
Illinois College of Optometry/Illinois Eye Institute, Chicago, Illinois, United States
🇺🇸
SUNY College of Optometry/University Optometric Center, New York, New York, United States
🇺🇸
The Ohio State University, Columbus, Ohio, United States

and more 1 locations

Study of Eyes and Attention Deficit (SEAD)

Completed

Conditions: ADHD
Convergence Insufficiency
Accommodative Insufficiency

First Posted Date: 2007-05-11

Last Posted Date: 2008-07-03

Lead Sponsor: Ohio State University

Target Recruit Count: 75

Registration Number: NCT00472511

Study of Eye Movement Testing and Therapy

Not Applicable

Completed

Conditions: Saccadic Eye Movement Deficiency
Oculomotor Deficiency
Oculomotor Dysfunction

First Posted Date: 2007-05-11

Last Posted Date: 2008-07-03

Lead Sponsor: Ohio State University

Target Recruit Count: 40

Registration Number: NCT00472485

Locations: 🇺🇸
The Ohio State University, Columbus, Ohio, United States

Cycloplegic Delivery Investigation

Not Applicable

Completed

Conditions: Healthy

First Posted Date: 2007-05-11

Last Posted Date: 2008-07-03

Lead Sponsor: Ohio State University

Target Recruit Count: 50

Registration Number: NCT00472524

Evaluating NeuroVision's Neural Vision Correction (NVC) Myopia Treatment

Not Applicable

Terminated

Conditions: Myopia

Interventions: Device: NeuroVision's NVC treatment for Low Myopia

First Posted Date: 2007-05-04

Last Posted Date: 2018-09-25

Lead Sponsor: Ohio State University

Target Recruit Count: 2

Registration Number: NCT00469612

Locations: 🇺🇸
College of Optometry, The Ohio State University, Columbus, Ohio, United States

Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.

Phase 3

Completed

Conditions: Oppositional Defiant Disorder
Conduct Disorder
Attention Deficit/Hyperactivity Disorder (ADHD)
Impulse-Control Disorders
Intermittent Explosive Disorder
Adjustment Disorder
Bipolar Disorder
Pervasive Developmental Disorder

First Posted Date: 2006-11-15

Last Posted Date: 2016-06-23

Lead Sponsor: Ohio State University

Target Recruit Count: 30

Registration Number: NCT00399698

Locations: 🇺🇸
Ohio State University Nisonger Center, Columbus, Ohio, United States

N-acetylcysteine in Intra-amniotic Infection/Inflammation

Phase 1

Completed

Conditions: Chorioamnionitis
Labor, Premature
Inflammation
Preterm Premature Rupture of the Membranes
Infection

Interventions: Procedure: amniocentesis
Drug: N-acetylcysteine or placebo

First Posted Date: 2006-11-09

Last Posted Date: 2018-10-10

Lead Sponsor: Ohio State University

Target Recruit Count: 68

Registration Number: NCT00397735

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
🇺🇸
The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States

Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva

Completed

Conditions: Patients Already Taking Risperidone for Clinical Indications

First Posted Date: 2006-11-03

Last Posted Date: 2016-06-23

Lead Sponsor: Ohio State University

Target Recruit Count: 19

Registration Number: NCT00395499

Locations: 🇺🇸
General Clinical Research Center, Columbus, Ohio, United States
🇺🇸
The Nisonger Center, Columbus, Ohio, United States

Fish Oil (Omega 3), Immune Function, and Mood

Phase 2

Completed

Conditions: Inflammation

Interventions: Dietary Supplement: Omega 3 (Fish Oil) Supplementation
Dietary Supplement: Placebo

First Posted Date: 2006-10-11

Last Posted Date: 2012-11-20

Lead Sponsor: Ohio State University

Target Recruit Count: 138

Registration Number: NCT00385723

Locations: 🇺🇸
The Ohio State University, Columbus, Ohio, United States

Study of the Relationship Between Blood Vessels and Insulin Response in Adolescents

Completed

Conditions: Stroke
Diabetes Mellitus, Type 2
Hypertension
Heart Disease

First Posted Date: 2006-09-11

Last Posted Date: 2016-06-08

Lead Sponsor: Ohio State University

Target Recruit Count: 66

Registration Number: NCT00374361

Locations: 🇺🇸
Ohio State University, Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy